Exact Mass: 673.5433655999999

Exact Mass Matches: 673.5433655999999

Found 421 metabolites which its exact mass value is equals to given mass value 673.5433655999999, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

PE(14:0/P-18:1(11Z))

(2-aminoethoxy)[(2R)-2-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]-3-(tetradecanoyloxy)propoxy]phosphinic acid

C37H72NO7P (673.5046132)


PE(14:0/P-18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(14:0/P-18:1(11Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PE(14:0/P-18:1(9Z))

(2-aminoethoxy)[(2R)-2-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]-3-(tetradecanoyloxy)propoxy]phosphinic acid

C37H72NO7P (673.5046132)


PE(14:0/P-18:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(14:0/P-18:1(9Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PE(14:1(9Z)/P-18:0)

(2-aminoethoxy)[(2R)-2-[(1Z)-octadec-1-en-1-yloxy]-3-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphinic acid

C37H72NO7P (673.5046132)


PE(14:1(9Z)/P-18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(14:1(9Z)/P-18:0), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PE(16:1(9Z)/P-16:0)

(2-aminoethoxy)[(2R)-2-[(1Z)-hexadec-1-en-1-yloxy]-3-[(9Z)-hexadec-9-enoyloxy]propoxy]phosphinic acid

C37H72NO7P (673.5046132)


PE(16:1(9Z)/P-16:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(16:1(9Z)/P-16:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the plasmalogen 16:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(16:1(9Z)/P-16:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(16:1(9Z)/P-16:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the plasmalogen 16:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

CerP(d18:1/20:0)

[(e,2S,3R)-3-Hydroxy-2-(icosanoylamino)octadec-4-enyl] dihydrogen phosphate

C38H76NO6P (673.5409966)


CerP(d18:1/20:0) is a ceramide 1-phosphate belonging to the sphingolipid class of molecules. Ceramides are amides of fatty acids with long-chain di- or trihydroxy bases, the commonest in animals being sphingosine and in plants phytosphingosine. The acyl group of ceramides is generally a long-chain saturated or monounsaturated fatty acid. The most frequent fatty acids found in animal ceramides are 18:0, 24:0 and 24:1(n-9). Ceramide 1-phosphates are produced by phosphorylation of ceramide by a specific ceramide kinase. Ceramide-1-phosphate was shown to be a specific and potent inducer of arachidonic acid and prostanoid synthesis in cells through the translocation and activation of the cytoplasmic phospholipase A2. [HMDB] CerP(d18:1/20:0) is a ceramide 1-phosphate belonging to the sphingolipid class of molecules. Ceramides are amides of fatty acids with long-chain di- or trihydroxy bases, the commonest in animals being sphingosine and in plants phytosphingosine. The acyl group of ceramides is generally a long-chain saturated or monounsaturated fatty acid. The most frequent fatty acids found in animal ceramides are 18:0, 24:0 and 24:1(n-9). Ceramide 1-phosphates are produced by phosphorylation of ceramide by a specific ceramide kinase. Ceramide-1-phosphate was shown to be a specific and potent inducer of arachidonic acid and prostanoid synthesis in cells through the translocation and activation of the cytoplasmic phospholipase A2.

   

PE(P-16:0/16:1(9Z))

(2-aminoethoxy)[(2R)-3-[(1Z)-hexadec-1-en-1-yloxy]-2-[(9Z)-hexadec-9-enoyloxy]propoxy]phosphinic acid

C37H72NO7P (673.5046132)


PE(P-16:0/16:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-16:0/16:1(9Z)), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of palmitoleic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-16:0/16:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-16:0/16:1(9Z)), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of palmitoleic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(P-18:0/14:1(9Z))

(2-aminoethoxy)[(2R)-3-[(1Z)-octadec-1-en-1-yloxy]-2-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphinic acid

C37H72NO7P (673.5046132)


PE(P-18:0/14:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:0/14:1(9Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of myristoleic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-18:0/14:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:0/14:1(9Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of myristoleic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(P-18:1(11Z)/14:0)

(2-aminoethoxy)[(2R)-3-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]-2-(tetradecanoyloxy)propoxy]phosphinic acid

C37H72NO7P (673.5046132)


PE(P-18:1(11Z)/14:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(11Z)/14:0), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of myristic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-18:1(11Z)/14:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(11Z)/14:0), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of myristic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(P-18:1(9Z)/14:0)

(2-aminoethoxy)[(2R)-3-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]-2-(tetradecanoyloxy)propoxy]phosphinic acid

C37H72NO7P (673.5046132)


PE(P-18:1(9Z)/14:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(9Z)/14:0), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of myristic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-18:1(9Z)/14:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(9Z)/14:0), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of myristic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

(2-aminoethoxy)[3-[hexadec-1-en-1-yloxy]-2-[hexadec-9-enoyloxy]propoxy]phosphinic acid

(2-aminoethoxy)[3-[hexadec-1-en-1-yloxy]-2-[hexadec-9-enoyloxy]propoxy]phosphinic acid

C37H72NO7P (673.5046132)


   

C20 CerP

N-(eicosanoyl)-sphing-4-enine-1-phosphate

C38H76NO6P (673.5409966)


   

C14DH GlcCer

N-(tetradecanoyl)-1-beta-glucosyl-sphinganine

C38H75NO8 (673.5492390000001)


   

PE(32:1)

1-(1-Enyl-palmitoyl)-2-palmitoleoyl-sn-glycero-3-phosphoethanolamine

C37H72NO7P (673.5046132)


   

PE O-32:2

1-(1Z-octadecenyl)-2-(9Z-tetradecenoyl)-glycero-3-phosphoethanolamine

C37H72NO7P (673.5046132)


   

2-[hydroxy-[(2S,3R,4E,14Z)-3-hydroxy-2-(tetradecanoylamino)octadeca-4,14-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,14Z)-3-hydroxy-2-(tetradecanoylamino)octadeca-4,14-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

alpha-D-galactosyl-N-tetradecanoylsphinganine

alpha-D-galactosyl-N-tetradecanoylsphinganine

C38H75NO8 (673.5492390000001)


A glycodihydroceramide having alpha-D-galactosyl component and the ceramide N-acyl group specified as tetradecanoyl.

   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] (Z)-hexadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] (Z)-hexadec-9-enoate

C37H72NO7P (673.5046132)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] tetradecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] tetradecanoate

C37H72NO7P (673.5046132)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (21Z,24Z)-dotriaconta-21,24-dienoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (21Z,24Z)-dotriaconta-21,24-dienoate

C37H72NO7P (673.5046132)


   

(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenamide

(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenamide

C45H71NO3 (673.5433655999999)


   

HexCer 16:1;2O/15:0;O

HexCer 16:1;2O/15:0;O

C37H71NO9 (673.5128556)


   

HexCer 18:1;2O/13:0;O

HexCer 18:1;2O/13:0;O

C37H71NO9 (673.5128556)


   

HexCer 18:0;2O/13:1;O

HexCer 18:0;2O/13:1;O

C37H71NO9 (673.5128556)


   

HexCer 19:0;2O/12:1;O

HexCer 19:0;2O/12:1;O

C37H71NO9 (673.5128556)


   

HexCer 19:1;2O/12:0;O

HexCer 19:1;2O/12:0;O

C37H71NO9 (673.5128556)


   

HexCer 17:1;2O/14:0;O

HexCer 17:1;2O/14:0;O

C37H71NO9 (673.5128556)


   

HexCer 16:0;2O/15:1;O

HexCer 16:0;2O/15:1;O

C37H71NO9 (673.5128556)


   

HexCer 17:0;2O/14:1;O

HexCer 17:0;2O/14:1;O

C37H71NO9 (673.5128556)


   

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-octoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-octoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046132)


   

(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-N-[(4E,8E,12E)-1,3-dihydroxyheptadeca-4,8,12-trien-2-yl]octacosa-7,10,13,16,19,22,25-heptaenamide

(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-N-[(4E,8E,12E)-1,3-dihydroxyheptadeca-4,8,12-trien-2-yl]octacosa-7,10,13,16,19,22,25-heptaenamide

C45H71NO3 (673.5433655999999)


   

(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(E)-1,3-dihydroxytridec-4-en-2-yl]dotriaconta-5,8,11,14,17,20,23,26,29-nonaenamide

(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(E)-1,3-dihydroxytridec-4-en-2-yl]dotriaconta-5,8,11,14,17,20,23,26,29-nonaenamide

C45H71NO3 (673.5433655999999)


   

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]triaconta-6,9,12,15,18,21,24,27-octaenamide

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]triaconta-6,9,12,15,18,21,24,27-octaenamide

C45H71NO3 (673.5433655999999)


   

(9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]triaconta-9,12,15,18,21,24,27-heptaenamide

(9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]triaconta-9,12,15,18,21,24,27-heptaenamide

C45H71NO3 (673.5433655999999)


   

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-(1,3-dihydroxynonan-2-yl)hexatriaconta-6,9,12,15,18,21,24,27,30,33-decaenamide

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-(1,3-dihydroxynonan-2-yl)hexatriaconta-6,9,12,15,18,21,24,27,30,33-decaenamide

C45H71NO3 (673.5433655999999)


   

(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-N-[(4E,8E,12E)-1,3-dihydroxynonadeca-4,8,12-trien-2-yl]hexacosa-5,8,11,14,17,20,23-heptaenamide

(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-N-[(4E,8E,12E)-1,3-dihydroxynonadeca-4,8,12-trien-2-yl]hexacosa-5,8,11,14,17,20,23-heptaenamide

C45H71NO3 (673.5433655999999)


   

(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]dotriaconta-8,11,14,17,20,23,26,29-octaenamide

(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]dotriaconta-8,11,14,17,20,23,26,29-octaenamide

C45H71NO3 (673.5433655999999)


   

(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(E)-1,3-dihydroxyundec-4-en-2-yl]tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenamide

(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(E)-1,3-dihydroxyundec-4-en-2-yl]tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenamide

C45H71NO3 (673.5433655999999)


   

(E)-3-hydroxy-2-(2-hydroxyhexadecanoylamino)docos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxyhexadecanoylamino)docos-4-ene-1-sulfonic acid

C38H75NO6S (673.531481)


   

3-hydroxy-2-[[(Z)-2-hydroxynonadec-9-enoyl]amino]nonadecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxynonadec-9-enoyl]amino]nonadecane-1-sulfonic acid

C38H75NO6S (673.531481)


   

3-hydroxy-2-[[(Z)-2-hydroxyoctadec-11-enoyl]amino]icosane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxyoctadec-11-enoyl]amino]icosane-1-sulfonic acid

C38H75NO6S (673.531481)


   

3-hydroxy-2-[[(Z)-2-hydroxypentadec-9-enoyl]amino]tricosane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxypentadec-9-enoyl]amino]tricosane-1-sulfonic acid

C38H75NO6S (673.531481)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(15Z,18Z)-hexacosa-15,18-dienoxy]propan-2-yl] hexanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(15Z,18Z)-hexacosa-15,18-dienoxy]propan-2-yl] hexanoate

C37H72NO7P (673.5046132)


   

(E)-3-hydroxy-2-(2-hydroxypentacosanoylamino)tridec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxypentacosanoylamino)tridec-4-ene-1-sulfonic acid

C38H75NO6S (673.531481)


   

3-hydroxy-2-[[(Z)-2-hydroxyhenicos-9-enoyl]amino]heptadecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxyhenicos-9-enoyl]amino]heptadecane-1-sulfonic acid

C38H75NO6S (673.531481)


   

(E)-3-hydroxy-2-(2-hydroxytridecanoylamino)pentacos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxytridecanoylamino)pentacos-4-ene-1-sulfonic acid

C38H75NO6S (673.531481)


   

3-hydroxy-2-[[(Z)-2-hydroxytricos-11-enoyl]amino]pentadecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxytricos-11-enoyl]amino]pentadecane-1-sulfonic acid

C38H75NO6S (673.531481)


   

3-hydroxy-2-[[(Z)-2-hydroxyhexadec-7-enoyl]amino]docosane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxyhexadec-7-enoyl]amino]docosane-1-sulfonic acid

C38H75NO6S (673.531481)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C37H72NO7P (673.5046132)


   

(E)-3-hydroxy-2-(2-hydroxydocosanoylamino)hexadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxydocosanoylamino)hexadec-4-ene-1-sulfonic acid

C38H75NO6S (673.531481)


   

3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]pentacosane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]pentacosane-1-sulfonic acid

C38H75NO6S (673.531481)


   

(E)-3-hydroxy-2-(2-hydroxyhexacosanoylamino)dodec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxyhexacosanoylamino)dodec-4-ene-1-sulfonic acid

C38H75NO6S (673.531481)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] octanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] octanoate

C37H72NO7P (673.5046132)


   

3-hydroxy-2-[[(Z)-2-hydroxytetracos-11-enoyl]amino]tetradecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxytetracos-11-enoyl]amino]tetradecane-1-sulfonic acid

C38H75NO6S (673.531481)


   

(E)-3-hydroxy-2-(2-hydroxytetradecanoylamino)tetracos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxytetradecanoylamino)tetracos-4-ene-1-sulfonic acid

C38H75NO6S (673.531481)


   

(E)-3-hydroxy-2-(2-hydroxyoctadecanoylamino)icos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxyoctadecanoylamino)icos-4-ene-1-sulfonic acid

C38H75NO6S (673.531481)


   

3-hydroxy-2-[[(Z)-2-hydroxytetradec-9-enoyl]amino]tetracosane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxytetradec-9-enoyl]amino]tetracosane-1-sulfonic acid

C38H75NO6S (673.531481)


   

(E)-3-hydroxy-2-(2-hydroxypentadecanoylamino)tricos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxypentadecanoylamino)tricos-4-ene-1-sulfonic acid

C38H75NO6S (673.531481)


   

3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]hexacosane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]hexacosane-1-sulfonic acid

C38H75NO6S (673.531481)


   

(E)-3-hydroxy-2-(2-hydroxyheptadecanoylamino)henicos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxyheptadecanoylamino)henicos-4-ene-1-sulfonic acid

C38H75NO6S (673.531481)


   

3-hydroxy-2-[[(Z)-2-hydroxydocos-11-enoyl]amino]hexadecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxydocos-11-enoyl]amino]hexadecane-1-sulfonic acid

C38H75NO6S (673.531481)


   

(E)-3-hydroxy-2-(2-hydroxydodecanoylamino)hexacos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxydodecanoylamino)hexacos-4-ene-1-sulfonic acid

C38H75NO6S (673.531481)


   

3-hydroxy-2-[[(Z)-2-hydroxyicos-11-enoyl]amino]octadecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxyicos-11-enoyl]amino]octadecane-1-sulfonic acid

C38H75NO6S (673.531481)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propan-2-yl] butanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propan-2-yl] butanoate

C37H72NO7P (673.5046132)


   

3-hydroxy-2-[[(Z)-2-hydroxypentacos-11-enoyl]amino]tridecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxypentacos-11-enoyl]amino]tridecane-1-sulfonic acid

C38H75NO6S (673.531481)


   

3-hydroxy-2-[[(Z)-2-hydroxyhexacos-11-enoyl]amino]dodecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxyhexacos-11-enoyl]amino]dodecane-1-sulfonic acid

C38H75NO6S (673.531481)


   

(E)-3-hydroxy-2-(2-hydroxytricosanoylamino)pentadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxytricosanoylamino)pentadec-4-ene-1-sulfonic acid

C38H75NO6S (673.531481)


   

(E)-3-hydroxy-2-(2-hydroxynonadecanoylamino)nonadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxynonadecanoylamino)nonadec-4-ene-1-sulfonic acid

C38H75NO6S (673.531481)


   

(E)-3-hydroxy-2-(2-hydroxyhenicosanoylamino)heptadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxyhenicosanoylamino)heptadec-4-ene-1-sulfonic acid

C38H75NO6S (673.531481)


   

(E)-3-hydroxy-2-(2-hydroxytetracosanoylamino)tetradec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxytetracosanoylamino)tetradec-4-ene-1-sulfonic acid

C38H75NO6S (673.531481)


   

(E)-3-hydroxy-2-(2-hydroxyicosanoylamino)octadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxyicosanoylamino)octadec-4-ene-1-sulfonic acid

C38H75NO6S (673.531481)


   

[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-nonanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-nonanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046132)


   

[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-heptanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-heptanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046132)


   

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-nonoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-nonoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046132)


   

[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-octanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-octanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046132)


   

[2-pentanoyloxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-pentanoyloxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046132)


   

[3-[(15Z,18Z)-hexacosa-15,18-dienoxy]-2-propanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(15Z,18Z)-hexacosa-15,18-dienoxy]-2-propanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046132)


   

3-Hydroxy-2-(tetradecanoylamino)pentacosane-1-sulfonic acid

3-Hydroxy-2-(tetradecanoylamino)pentacosane-1-sulfonic acid

C39H79NO5S (673.5678644)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-nonadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-nonadec-9-enoate

C37H72NO7P (673.5046132)


   

2-(Heptadecanoylamino)-3-hydroxydocosane-1-sulfonic acid

2-(Heptadecanoylamino)-3-hydroxydocosane-1-sulfonic acid

C39H79NO5S (673.5678644)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C37H72NO7P (673.5046132)


   

Cer 22:3;3O/20:2;(2OH)

Cer 22:3;3O/20:2;(2OH)

C42H75NO5 (673.564494)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] tridecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] tridecanoate

C37H72NO7P (673.5046132)


   

Cer 18:3;3O/24:2;(2OH)

Cer 18:3;3O/24:2;(2OH)

C42H75NO5 (673.564494)


   

3-Hydroxy-2-(nonadecanoylamino)icosane-1-sulfonic acid

3-Hydroxy-2-(nonadecanoylamino)icosane-1-sulfonic acid

C39H79NO5S (673.5678644)


   

3-Hydroxy-2-(pentadecanoylamino)tetracosane-1-sulfonic acid

3-Hydroxy-2-(pentadecanoylamino)tetracosane-1-sulfonic acid

C39H79NO5S (673.5678644)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C37H72NO7P (673.5046132)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] pentadecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] pentadecanoate

C37H72NO7P (673.5046132)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C37H72NO7P (673.5046132)


   

2-(Henicosanoylamino)-3-hydroxyoctadecane-1-sulfonic acid

2-(Henicosanoylamino)-3-hydroxyoctadecane-1-sulfonic acid

C39H79NO5S (673.5678644)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] (Z)-tridec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] (Z)-tridec-9-enoate

C37H72NO7P (673.5046132)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C37H72NO7P (673.5046132)


   

2-(Hexadecanoylamino)-3-hydroxytricosane-1-sulfonic acid

2-(Hexadecanoylamino)-3-hydroxytricosane-1-sulfonic acid

C39H79NO5S (673.5678644)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] (Z)-pentadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] (Z)-pentadec-9-enoate

C37H72NO7P (673.5046132)


   

3-Hydroxy-2-(icosanoylamino)nonadecane-1-sulfonic acid

3-Hydroxy-2-(icosanoylamino)nonadecane-1-sulfonic acid

C39H79NO5S (673.5678644)


   

Cer 26:3;3O/16:2;(2OH)

Cer 26:3;3O/16:2;(2OH)

C42H75NO5 (673.564494)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C37H72NO7P (673.5046132)


   

2-(Hexacosanoylamino)-3-hydroxytridecane-1-sulfonic acid

2-(Hexacosanoylamino)-3-hydroxytridecane-1-sulfonic acid

C39H79NO5S (673.5678644)


   

3-Hydroxy-2-(tetracosanoylamino)pentadecane-1-sulfonic acid

3-Hydroxy-2-(tetracosanoylamino)pentadecane-1-sulfonic acid

C39H79NO5S (673.5678644)


   

Cer 20:3;3O/22:2;(2OH)

Cer 20:3;3O/22:2;(2OH)

C42H75NO5 (673.564494)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propan-2-yl] undecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propan-2-yl] undecanoate

C37H72NO7P (673.5046132)


   

Cer 24:3;3O/18:2;(2OH)

Cer 24:3;3O/18:2;(2OH)

C42H75NO5 (673.564494)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propan-2-yl] decanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propan-2-yl] decanoate

C37H72NO7P (673.5046132)


   

3-Hydroxy-2-(tridecanoylamino)hexacosane-1-sulfonic acid

3-Hydroxy-2-(tridecanoylamino)hexacosane-1-sulfonic acid

C39H79NO5S (673.5678644)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] dodecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] dodecanoate

C37H72NO7P (673.5046132)


   

3-Hydroxy-2-(pentacosanoylamino)tetradecane-1-sulfonic acid

3-Hydroxy-2-(pentacosanoylamino)tetradecane-1-sulfonic acid

C39H79NO5S (673.5678644)


   

3-Hydroxy-2-(octadecanoylamino)henicosane-1-sulfonic acid

3-Hydroxy-2-(octadecanoylamino)henicosane-1-sulfonic acid

C39H79NO5S (673.5678644)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (Z)-heptadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (Z)-heptadec-9-enoate

C37H72NO7P (673.5046132)


   

2-(Docosanoylamino)-3-hydroxyheptadecane-1-sulfonic acid

2-(Docosanoylamino)-3-hydroxyheptadecane-1-sulfonic acid

C39H79NO5S (673.5678644)


   

3-Hydroxy-2-(tricosanoylamino)hexadecane-1-sulfonic acid

3-Hydroxy-2-(tricosanoylamino)hexadecane-1-sulfonic acid

C39H79NO5S (673.5678644)


   

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-undecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-undecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046132)


   

[2-decanoyloxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-decanoyloxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046132)


   

[3-[(Z)-pentadec-9-enoxy]-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(Z)-pentadec-9-enoxy]-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046132)


   

[3-decoxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-decoxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046132)


   

[2-dodecanoyloxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-dodecanoyloxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046132)


   

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-tridecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-tridecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046132)


   

[3-dodecoxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-dodecoxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046132)


   

[2-[(Z)-hexadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-hexadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046132)


   

2-[4-(12-hydroxy-10,13-dimethyl-3-pentadecanoyloxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoylamino]acetic acid

2-[4-(12-hydroxy-10,13-dimethyl-3-pentadecanoyloxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoylamino]acetic acid

C41H71NO6 (673.5281106)


   

Cer 14:0;2O/12:0;(3OH)(FA 16:4)

Cer 14:0;2O/12:0;(3OH)(FA 16:4)

C42H75NO5 (673.564494)


   

Cer 14:0;2O/16:4;(3OH)(FA 12:0)

Cer 14:0;2O/16:4;(3OH)(FA 12:0)

C42H75NO5 (673.564494)


   
   
   
   
   
   
   
   
   

N-(tetracosanoyl)-4E-tetradecasphingenine-1-phosphate

N-(tetracosanoyl)-4E-tetradecasphingenine-1-phosphate

C38H76NO6P (673.5409966)


   

N-(docosanoyl)-4E-hexadecasphingenine-1-phosphate

N-(docosanoyl)-4E-hexadecasphingenine-1-phosphate

C38H76NO6P (673.5409966)


   
   

[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046132)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (Z)-octadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (Z)-octadec-9-enoate

C37H72NO7P (673.5046132)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C37H72NO7P (673.5046132)


   

[3-[(Z)-hexadec-9-enoxy]-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(Z)-hexadec-9-enoxy]-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046132)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (Z)-tetradec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (Z)-tetradec-9-enoate

C37H72NO7P (673.5046132)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] hexadecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] hexadecanoate

C37H72NO7P (673.5046132)


   

[2-[(Z)-pentadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-pentadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046132)


   

[3-[(9Z,12Z)-octadeca-9,12-dienoxy]-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(9Z,12Z)-octadeca-9,12-dienoxy]-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046132)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C37H72NO7P (673.5046132)


   

N-(dodecanoyl)-1-beta-glucosyl-eicosasphinganine

N-(dodecanoyl)-1-beta-glucosyl-eicosasphinganine

C38H75NO8 (673.5492390000001)


   

N-(pentadecanoyl)-1-beta-glucosyl-heptadecasphinganine

N-(pentadecanoyl)-1-beta-glucosyl-heptadecasphinganine

C38H75NO8 (673.5492390000001)


   

N-(decanoyl)-1-beta-glucosyl-docosasphinganine

N-(decanoyl)-1-beta-glucosyl-docosasphinganine

C38H75NO8 (673.5492390000001)


   

N-(tridecanoyl)-1-beta-glucosyl-nonadecasphinganine

N-(tridecanoyl)-1-beta-glucosyl-nonadecasphinganine

C38H75NO8 (673.5492390000001)


   

2-[[(E,2S,3R)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxypentadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E,2S,3R)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxypentadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(tetradecanoylamino)octadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(tetradecanoylamino)octadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(2S,3R,4E,6E)-3-hydroxy-2-(octadecanoylamino)tetradeca-4,6-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,6E)-3-hydroxy-2-(octadecanoylamino)tetradeca-4,6-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(pentadecanoylamino)heptadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(pentadecanoylamino)heptadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]octadecanamide

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]octadecanamide

C38H75NO8 (673.5492390000001)


   

2-[[(2S,3R,4E,6E)-2-(heptadecanoylamino)-3-hydroxypentadeca-4,6-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,6E)-2-(heptadecanoylamino)-3-hydroxypentadeca-4,6-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[(2S,3R,4E,8E)-2-(heptadecanoylamino)-3-hydroxypentadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,8E)-2-(heptadecanoylamino)-3-hydroxypentadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(tridecanoylamino)nonadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(tridecanoylamino)nonadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadecan-2-yl]heptadecanamide

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadecan-2-yl]heptadecanamide

C38H75NO8 (673.5492390000001)


   

2-[[(E,2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E,2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-1-enoxy]propan-2-yl] (E)-hexadec-7-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-1-enoxy]propan-2-yl] (E)-hexadec-7-enoate

C37H72NO7P (673.5046132)


   

2-[[(E,2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxyhexadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E,2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxyhexadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(2S,3R,4E,14E)-3-hydroxy-2-(tetradecanoylamino)octadeca-4,14-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,14E)-3-hydroxy-2-(tetradecanoylamino)octadeca-4,14-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[(2S,3R,4E,8E)-2-(dodecanoylamino)-3-hydroxyicosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,8E)-2-(dodecanoylamino)-3-hydroxyicosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[(2R,3S,4E,8E)-2-(decanoylamino)-3-hydroxydocosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2R,3S,4E,8E)-2-(decanoylamino)-3-hydroxydocosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]tetradecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]tetradecoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadecan-2-yl]hexadecanamide

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadecan-2-yl]hexadecanamide

C38H75NO8 (673.5492390000001)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-1-enoxy]propan-2-yl] (E)-hexadec-9-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-1-enoxy]propan-2-yl] (E)-hexadec-9-enoate

C37H72NO7P (673.5046132)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-1-enoxy]propan-2-yl] (E)-tetradec-9-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-1-enoxy]propan-2-yl] (E)-tetradec-9-enoate

C37H72NO7P (673.5046132)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]tetradec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]tetradec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(octadecanoylamino)tetradeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(octadecanoylamino)tetradeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[(2S,3R,4E,6E)-2-(hexadecanoylamino)-3-hydroxyhexadeca-4,6-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,6E)-2-(hexadecanoylamino)-3-hydroxyhexadeca-4,6-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]tetradec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]tetradec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[(E,2S,3R)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxypentadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E,2S,3R)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxypentadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[(2S,3R,4E,8E)-2-(hexadecanoylamino)-3-hydroxyhexadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,8E)-2-(hexadecanoylamino)-3-hydroxyhexadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

[(2S,3R)-3-hydroxy-2-[[(E)-tetracos-15-enoyl]amino]tetradecyl] dihydrogen phosphate

[(2S,3R)-3-hydroxy-2-[[(E)-tetracos-15-enoyl]amino]tetradecyl] dihydrogen phosphate

C38H76NO6P (673.5409966)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(tetradecanoylamino)octadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(tetradecanoylamino)octadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[2-[[(4Z,7Z)-hexadeca-4,7-dienoyl]amino]-3-hydroxyhexadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(4Z,7Z)-hexadeca-4,7-dienoyl]amino]-3-hydroxyhexadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(pentadecanoylamino)heptadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(pentadecanoylamino)heptadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[3-hydroxy-2-[[(10Z,12Z)-octadeca-10,12-dienoyl]amino]tetradecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(10Z,12Z)-octadeca-10,12-dienoyl]amino]tetradecoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]tetradec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]tetradec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[(4E,8E)-2-(heptadecanoylamino)-3-hydroxypentadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(heptadecanoylamino)-3-hydroxypentadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(tridecanoylamino)nonadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(tridecanoylamino)nonadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[(E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]heptadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]heptadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[(E)-2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[(4E,8E)-2-(dodecanoylamino)-3-hydroxyicosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(dodecanoylamino)-3-hydroxyicosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(octadecanoylamino)tetradeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(octadecanoylamino)tetradeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]nonadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]nonadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[(4E,8E)-2-(hexadecanoylamino)-3-hydroxyhexadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(hexadecanoylamino)-3-hydroxyhexadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxydecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxydecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[(E)-2-[[(Z)-docos-13-enoyl]amino]-3-hydroxydec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-docos-13-enoyl]amino]-3-hydroxydec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[(E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxyundec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxyundec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]nonadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]nonadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]dodec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]dodec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]tridecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]tridecoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[(4E,8E)-2-(heptanoylamino)-3-hydroxypentacosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(heptanoylamino)-3-hydroxypentacosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(pentanoylamino)heptacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(pentanoylamino)heptacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxypentadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxypentadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[(4E,8E)-2-(butanoylamino)-3-hydroxyoctacosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(butanoylamino)-3-hydroxyoctacosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxyundecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxyundecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]tridec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]tridec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(nonanoylamino)tricosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(nonanoylamino)tricosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(undecanoylamino)henicosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(undecanoylamino)henicosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[(4E,8E)-2-(decanoylamino)-3-hydroxydocosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(decanoylamino)-3-hydroxydocosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]tetradecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]tetradecoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[(4E,8E)-2-acetamido-3-hydroxytriaconta-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-acetamido-3-hydroxytriaconta-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(octanoylamino)tetracosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(octanoylamino)tetracosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxyhexadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxyhexadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]tetradec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]tetradec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[(4E,8E)-2-(hexanoylamino)-3-hydroxyhexacosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(hexanoylamino)-3-hydroxyhexacosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]oct-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]oct-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[[(E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxypentadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxypentadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]dodecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]dodecoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(icosanoylamino)dodeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(icosanoylamino)dodeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]octoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]octoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(propanoylamino)nonacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(propanoylamino)nonacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(nonadecanoylamino)trideca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(nonadecanoylamino)trideca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C37H74N2O6P+ (673.5284214000001)


   

N-icosanoylsphingosine 1-phosphate

N-icosanoylsphingosine 1-phosphate

C38H76NO6P (673.5409966)


A ceramide 1-phosphate that is the N-icosanoyl derivative of sphingosine.

   

Hex1Cer(32:0)

Hex1Cer(d16:0_16:0)

C38H75NO8 (673.5492390000001)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

MePC(28:2)

MePC(10:0(1)_18:2)

C37H72NO7P (673.5046132)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Hex1Cer(31:1)

Hex1Cer(d17:1_14:0(1+O))

C37H71NO9 (673.5128556)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   
   
   

PC P-14:0/15:1 or PC O-14:1/15:1

PC P-14:0/15:1 or PC O-14:1/15:1

C37H72NO7P (673.5046132)


   
   

PC P-16:1/13:0 or PC O-16:2/13:0

PC P-16:1/13:0 or PC O-16:2/13:0

C37H72NO7P (673.5046132)


   
   

PC P-18:1/11:0 or PC O-18:2/11:0

PC P-18:1/11:0 or PC O-18:2/11:0

C37H72NO7P (673.5046132)


   
   

PC P-29:1 or PC O-29:2

PC P-29:1 or PC O-29:2

C37H72NO7P (673.5046132)


   
   
   
   
   
   
   
   
   
   
   

PE P-14:0/18:1 or PE O-14:1/18:1

PE P-14:0/18:1 or PE O-14:1/18:1

C37H72NO7P (673.5046132)


   
   

PE P-16:0/16:1 or PE O-16:1/16:1

PE P-16:0/16:1 or PE O-16:1/16:1

C37H72NO7P (673.5046132)


   
   

PE P-16:1/16:0 or PE O-16:2/16:0

PE P-16:1/16:0 or PE O-16:2/16:0

C37H72NO7P (673.5046132)


   
   

PE P-17:1/15:0 or PE O-17:2/15:0

PE P-17:1/15:0 or PE O-17:2/15:0

C37H72NO7P (673.5046132)


   
   

PE P-18:0/14:1 or PE O-18:1/14:1

PE P-18:0/14:1 or PE O-18:1/14:1

C37H72NO7P (673.5046132)


   
   

PE P-18:1/14:0 or PE O-18:2/14:0

PE P-18:1/14:0 or PE O-18:2/14:0

C37H72NO7P (673.5046132)


   
   

PE P-20:1/12:0 or PE O-20:2/12:0

PE P-20:1/12:0 or PE O-20:2/12:0

C37H72NO7P (673.5046132)


   
   

PE P-22:1/10:0 or PE O-22:2/10:0

PE P-22:1/10:0 or PE O-22:2/10:0

C37H72NO7P (673.5046132)


   
   

PE P-32:1 or PE O-32:2

PE P-32:1 or PE O-32:2

C37H72NO7P (673.5046132)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

GalCer 14:0;O3/17:1

GalCer 14:0;O3/17:1

C37H71NO9 (673.5128556)


   

GalCer 14:1;O2/17:0;O

GalCer 14:1;O2/17:0;O

C37H71NO9 (673.5128556)


   
   

GalCer 15:0;O3/16:1

GalCer 15:0;O3/16:1

C37H71NO9 (673.5128556)


   

GalCer 15:1;O2/16:0;O

GalCer 15:1;O2/16:0;O

C37H71NO9 (673.5128556)


   
   

GalCer 16:0;O3/15:1

GalCer 16:0;O3/15:1

C37H71NO9 (673.5128556)


   

GalCer 16:1;O2/15:0;O

GalCer 16:1;O2/15:0;O

C37H71NO9 (673.5128556)


   
   

GalCer 17:0;O3/14:1

GalCer 17:0;O3/14:1

C37H71NO9 (673.5128556)


   

GalCer 17:1;O2/14:0;O

GalCer 17:1;O2/14:0;O

C37H71NO9 (673.5128556)


   
   

GalCer 18:1;O2/13:0;O

GalCer 18:1;O2/13:0;O

C37H71NO9 (673.5128556)


   
   

GalCer 19:1;O2/12:0;O

GalCer 19:1;O2/12:0;O

C37H71NO9 (673.5128556)


   
   

GalCer 20:1;O2/11:0;O

GalCer 20:1;O2/11:0;O

C37H71NO9 (673.5128556)


   
   

GalCer 21:1;O2/10:0;O

GalCer 21:1;O2/10:0;O

C37H71NO9 (673.5128556)


   
   
   
   
   
   

GlcCer 14:0;O3/17:1

GlcCer 14:0;O3/17:1

C37H71NO9 (673.5128556)


   

GlcCer 14:1;O2/17:0;O

GlcCer 14:1;O2/17:0;O

C37H71NO9 (673.5128556)


   
   

GlcCer 15:0;O3/16:1

GlcCer 15:0;O3/16:1

C37H71NO9 (673.5128556)


   

GlcCer 15:1;O2/16:0;O

GlcCer 15:1;O2/16:0;O

C37H71NO9 (673.5128556)


   
   

GlcCer 16:0;O3/15:1

GlcCer 16:0;O3/15:1

C37H71NO9 (673.5128556)


   

GlcCer 16:1;O2/15:0;O

GlcCer 16:1;O2/15:0;O

C37H71NO9 (673.5128556)


   
   

GlcCer 17:0;O3/14:1

GlcCer 17:0;O3/14:1

C37H71NO9 (673.5128556)


   

GlcCer 17:1;O2/14:0;O

GlcCer 17:1;O2/14:0;O

C37H71NO9 (673.5128556)


   
   

GlcCer 18:1;O2/13:0;O

GlcCer 18:1;O2/13:0;O

C37H71NO9 (673.5128556)


   
   

GlcCer 19:1;O2/12:0;O

GlcCer 19:1;O2/12:0;O

C37H71NO9 (673.5128556)


   
   

GlcCer 20:1;O2/11:0;O

GlcCer 20:1;O2/11:0;O

C37H71NO9 (673.5128556)


   
   

GlcCer 21:1;O2/10:0;O

GlcCer 21:1;O2/10:0;O

C37H71NO9 (673.5128556)


   
   
   
   
   
   

HexCer 14:0;O3/17:1

HexCer 14:0;O3/17:1

C37H71NO9 (673.5128556)


   

HexCer 14:1;O2/17:0;2OH

HexCer 14:1;O2/17:0;2OH

C37H71NO9 (673.5128556)


   

HexCer 14:1;O2/17:0;3OH

HexCer 14:1;O2/17:0;3OH

C37H71NO9 (673.5128556)


   

HexCer 14:1;O2/17:0;O

HexCer 14:1;O2/17:0;O

C37H71NO9 (673.5128556)


   
   

HexCer 15:0;O3/16:1

HexCer 15:0;O3/16:1

C37H71NO9 (673.5128556)


   

HexCer 15:1;O2/16:0;2OH

HexCer 15:1;O2/16:0;2OH

C37H71NO9 (673.5128556)


   

HexCer 15:1;O2/16:0;3OH

HexCer 15:1;O2/16:0;3OH

C37H71NO9 (673.5128556)


   

HexCer 15:1;O2/16:0;O

HexCer 15:1;O2/16:0;O

C37H71NO9 (673.5128556)


   
   

HexCer 16:0;O3/15:1

HexCer 16:0;O3/15:1

C37H71NO9 (673.5128556)


   

HexCer 16:1;O2/15:0;2OH

HexCer 16:1;O2/15:0;2OH

C37H71NO9 (673.5128556)


   

HexCer 16:1;O2/15:0;3OH

HexCer 16:1;O2/15:0;3OH

C37H71NO9 (673.5128556)


   

HexCer 16:1;O2/15:0;O

HexCer 16:1;O2/15:0;O

C37H71NO9 (673.5128556)


   
   

HexCer 17:0;O3/14:1

HexCer 17:0;O3/14:1

C37H71NO9 (673.5128556)


   

HexCer 17:1;O2/14:0;2OH

HexCer 17:1;O2/14:0;2OH

C37H71NO9 (673.5128556)


   

HexCer 17:1;O2/14:0;3OH

HexCer 17:1;O2/14:0;3OH

C37H71NO9 (673.5128556)


   

HexCer 17:1;O2/14:0;O

HexCer 17:1;O2/14:0;O

C37H71NO9 (673.5128556)


   
   

HexCer 18:1;O2/13:0;2OH

HexCer 18:1;O2/13:0;2OH

C37H71NO9 (673.5128556)


   

HexCer 18:1;O2/13:0;3OH

HexCer 18:1;O2/13:0;3OH

C37H71NO9 (673.5128556)


   

HexCer 18:1;O2/13:0;O

HexCer 18:1;O2/13:0;O

C37H71NO9 (673.5128556)


   
   

HexCer 19:1;O2/12:0;2OH

HexCer 19:1;O2/12:0;2OH

C37H71NO9 (673.5128556)


   

HexCer 19:1;O2/12:0;3OH

HexCer 19:1;O2/12:0;3OH

C37H71NO9 (673.5128556)


   

HexCer 19:1;O2/12:0;O

HexCer 19:1;O2/12:0;O

C37H71NO9 (673.5128556)


   
   

HexCer 20:1;O2/11:0;2OH

HexCer 20:1;O2/11:0;2OH

C37H71NO9 (673.5128556)


   

HexCer 20:1;O2/11:0;3OH

HexCer 20:1;O2/11:0;3OH

C37H71NO9 (673.5128556)


   

HexCer 20:1;O2/11:0;O

HexCer 20:1;O2/11:0;O

C37H71NO9 (673.5128556)


   
   

HexCer 21:1;O2/10:0;2OH

HexCer 21:1;O2/10:0;2OH

C37H71NO9 (673.5128556)


   

HexCer 21:1;O2/10:0;3OH

HexCer 21:1;O2/10:0;3OH

C37H71NO9 (673.5128556)


   

HexCer 21:1;O2/10:0;O

HexCer 21:1;O2/10:0;O

C37H71NO9 (673.5128556)


   
   
   
   
   

S16961

S16961

C41H71NO6 (673.5281106)


S16961 is a nicotinic receptor agonist.